Aenova has announced plans to expand its Bad Aibling site.

With a total investment of around EUR 20 million in new production and packaging lines, the site offers a modern, high-volume infrastructure for the production of effervescent products and blister packaging.

Aenova is a leading global contract development and manufacturing organisation for the pharmaceutical and healthcare industries with approximately 4,000 employees and 14 production sites. At the Bad Aibling site, the competence center for blister packaging / third party packaging and for high volumes of effervescent products within the Aenova network, a total of around 20 million euros is now being invested in modernizing the machinery. Another new blister line was just put into operation in February 2025.

With ultra-modern, fast blister lines and a capacity of around 220 million blisters per year, customers in the blister and third-party packaging sector can now be served even better. In the area of effervescent products, another new strip packaging line was successfully commissioned at the beginning of the year. This means that two strip lines and one tube line are now available for effervescent products. More than 420 million effervescent tablets per year can now be produced and packaged in Bad Aibling. Further investments will follow, including a new explosion-proof fluid bed granulator for organic granulation. As a result, the site has a modern infrastructure that enables shorter delivery times and can grow with the customer.

"With these major investments, we can offer significantly increased production capacity on state-of-the-art, high-speed equipment and position ourselves as a preferred and strategic partner for our customers," explained Thomas Lemke, Managing Director of the Aenova site in Bad Aibling.